Skip to Content
With about 10,000 metal hip lawsuits filed around the country, jury selection in the second trial involving the DePuy ASR (Articular Surface Replacement) hip is underway in Cook County, Illinois with opening statements to begin mid-month. Meanwhile the jury is considering the evidence presented in Los Angeles Superior Court in […]
Author: Cal Warriner
Last month, the U.S. Food and Drug Administration issued a Safety Communication to set some general guidelines for physicians and patients who have metal-on-metal (MoM) hip implants. Last month the agency also issued a proposed order that would require MoM hip manufacturers to submit premarket approval (PMA) applications before they […]
It is a problem usually associated with aging. A hip joint can deteriorate with additional weight, after trauma or due to disease such as arthritis. For the sufferer, the symptoms may be difficulty walking, pain, stiffness and eventually hip replacement surgery. Whether a total hip replacement (THR) or a hip […]
One would like to think that physicians put their patients first. After all, they make a good salary and should not be swayed by some incentives thrown their way, right? Maybe, in some cases, the answer is no. A group of researchers at the University of Pennsylvania wanted to find […]
When our clients discover that their metal-on-metal (MoM) hip has failed and never went through U.S. Food and Drug Administration (FDA) approval for safety and efficacy, they ask – how did that happen? Most Americans do not understand that medical devices are largely unregulated, even for those devices that are […]
An MDL (multidistrict litigation) was established for the prosecution of individual personal injury lawsuits against Biomet in the fall of 2012. The Judicial Panel on Multidistrict Litigation (JPML) heard attorney arguments on September 20, 2012, at a hearing in New York City. The plaintiffs requested consolidation of the pending lawsuits […]
A Florida grandmother has filed a complaint against the maker of the antidepressant Zoloft over a birth injury suffered by her grandchild. The lawsuit was filed November 28, 2012 in federal court in the Northern District of Florida, which is in Pensacola. According to the complaint against drug maker Pfizer […]
This study published in the December issue of Arthritis Care & Research is the first to look at the risk factors that could lead to a revision after a primary total hip replacement (THR). In the U.S. population, identified by Medicare claims from 29 states, patients who were younger, taller […]
Next spring, the U.S. Supreme Court will soon look at the very profitable policy called “pay for delay.” Profitability in this case extends primarily to both the brand-name manufacturers and generic drug makers at the expense of the consumer. Estimates are “pay for delay,” costs consumers an extra $3.5.8 billion […]
January first marks a new chapter for medical device manufacturers, who will be required to pay an excise tax of 2.3 percent on total revenues. Medical devices range from small stents and CT scans to pacemakers, defibrillators, metal hips and synthetic surgical mesh. The $125-billion-a-year industry complains it will be […]
